{"product_id":"bpc-157","title":"BPC-157","description":"\u003ch2\u003eAbout BPC-157\u003c\/h2\u003e\n\u003cp\u003eBPC-157 is a synthetic pentadecapeptide corresponding to a partial sequence of Body Protection Compound, a protein fragment originally isolated from gastric juice. It is supplied as a lyophilized powder of high analytical purity and is studied in laboratory settings for its activity across several signaling systems associated with tissue integrity, vascular response and cellular stress regulation. Peptsche supplies BPC-157 strictly as a research material for controlled laboratory investigation.\u003c\/p\u003e\n\n\u003ch3\u003eAvailable Sizes\u003c\/h3\u003e\n\u003cp\u003eBPC-157 is supplied as high purity lyophilized powder in multiple vial sizes to support different experimental designs and study durations. All vials are sealed under inert conditions and accompanied by batch specific analytical documentation.\u003c\/p\u003e\n\u003cul\u003e\n\u003cli\u003eBPC-157 5 mg Vial\u003c\/li\u003e\n\u003cli\u003eBPC-157 10 mg Vial\u003c\/li\u003e\n\u003c\/ul\u003e\n\n\u003ch3\u003eProduct Specifications\u003c\/h3\u003e\n\u003ctable\u003e\n\u003ctbody\u003e\n\u003ctr\u003e\n\u003ctd\u003e\u003cstrong\u003eProduct\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd\u003eBPC-157 (5 mg \/ 10 mg) lyophilized powder in sealed glass vial\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003e\u003cstrong\u003eApplication\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd\u003eResearch peptide studied in angiogenesis, cytoprotection and cellular repair models\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003e\u003cstrong\u003eAppearance\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd\u003eSolid white powder\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003e\u003cstrong\u003eChemical Formula\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd\u003eC\u003csub\u003e62\u003c\/sub\u003eH\u003csub\u003e98\u003c\/sub\u003eN\u003csub\u003e16\u003c\/sub\u003eO\u003csub\u003e22\u003c\/sub\u003e\n\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003e\u003cstrong\u003eMolecular Weight\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd\u003e1419.5 g\/mol\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003e\u003cstrong\u003eCAS Number\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd\u003e137525-51-0\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003e\u003cstrong\u003ePubChem CID\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd\u003e\u003ca href=\"https:\/\/pubchem.ncbi.nlm.nih.gov\/compound\/9941957\" target=\"_blank\" rel=\"noopener\"\u003e9941957\u003c\/a\u003e\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003e\u003cstrong\u003eSequence\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd\u003eGly Glu Pro Pro Pro Gly Lys Pro Ala Asp Asp Ala Gly Leu Val\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003e\u003cstrong\u003eSynonyms\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd\u003eBPC157, BPC 157, Body Protection Compound 157, Pentadecapeptide BPC-157\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003e\u003cstrong\u003ePurity\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd\u003e99% or greater by HPLC, verified per batch\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003e\u003cstrong\u003eStorage\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd\u003eStore sealed at 2 to 8 °C, protected from heat, light and moisture\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003e\u003cstrong\u003eRegulatory Status\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd\u003eResearch use compound. Not approved for human or veterinary use.\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003c\/tbody\u003e\n\u003c\/table\u003e\n\n\u003ch2\u003eWhat is BPC-157?\u003c\/h2\u003e\n\u003cp\u003eBPC-157, also referred to as Body Protection Compound 157, is a stable synthetic peptide composed of fifteen amino acid residues. Its sequence corresponds to a fragment of a larger protein identified in gastric fluid, and the synthetic form is produced to a defined analytical specification for laboratory work rather than isolated from biological material.\u003c\/p\u003e\n\u003cp\u003eScientific interest in this peptide originated in gastrointestinal research, where investigators examined naturally occurring peptide fragments that appeared to contribute to mucosal integrity under experimental stress conditions. That early work broadened over time into a wider body of preclinical literature examining how the peptide behaves across several distinct model systems.\u003c\/p\u003e\n\u003cp\u003ePublished studies to date are overwhelmingly preclinical, comprising in vitro assays and animal models. Controlled human clinical evidence remains limited, and findings across the literature should be interpreted within the boundaries of the experimental systems in which they were produced. BPC-157 is not an approved therapeutic agent in any jurisdiction.\u003c\/p\u003e\n\n\u003ch2\u003eBPC-157 Mechanism of Action (Research Only)\u003c\/h2\u003e\n\u003cp\u003eIn experimental models BPC-157 demonstrates pleiotropic activity, meaning it has been observed to interact with several signaling systems rather than a single well defined receptor target. This characteristic is one of the principal reasons the compound has attracted sustained research attention.\u003c\/p\u003e\n\n\u003ch3\u003eStructural and Chemical Basis\u003c\/h3\u003e\n\u003cp\u003eAs a fifteen residue peptide, BPC-157 is short and comparatively stable relative to many larger peptide constructs. Its reported resistance to degradation in aqueous conditions has made it practical to work with in laboratory settings, and this stability profile is frequently cited as a factor in its use as an experimental tool compound.\u003c\/p\u003e\n\n\u003ch3\u003eNitric Oxide Signaling Modulation\u003c\/h3\u003e\n\u003cp\u003eOne of the more consistently reported observations across the literature concerns interaction with nitric oxide signaling. Work published in Scientific Reports examined modulatory effects on vasomotor tone and described activation of the Src, Caveolin 1 and endothelial nitric oxide synthase pathway in the models studied. Nitric oxide signaling is broadly implicated in vascular tone regulation and endothelial behaviour, which situates this observation within wider vascular research interest.\u003c\/p\u003e\n\n\u003ch3\u003eAngiogenesis and Vascular Response Pathways\u003c\/h3\u003e\n\u003cp\u003eAnimal and in vitro studies have examined BPC-157 in connection with angiogenic signaling, the process by which new vascular structures form from existing vessels. A review published in Current Pharmaceutical Design characterised the peptide as angiomodulatory and discussed its relationship to nitric oxide, VEGF and FAK signaling in the models reviewed, alongside vessel formation, edema and thrombogenesis.\u003c\/p\u003e\n\n\u003ch3\u003eIntegrated Mechanistic Profile\u003c\/h3\u003e\n\u003cp\u003eTaken together, the research literature suggests BPC-157 operates through overlapping mechanisms rather than one isolated pathway. Recurring themes across published work include:\u003c\/p\u003e\n\u003cul\u003e\n\u003cli\u003eModulation of nitric oxide and vascular signaling\u003c\/li\u003e\n\u003cli\u003eInfluence on angiogenic and endothelial responses\u003c\/li\u003e\n\u003cli\u003eRegulation of cellular stress and inflammatory balance\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp\u003eThis breadth is what positions the compound as a versatile research tool for examining tissue integrity across multiple model systems, and equally why mechanistic conclusions drawn from any single study should be treated as provisional.\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eNote:\u003c\/strong\u003e BPC-157 is supplied strictly for research use only. It is intended as an experimental compound for qualified laboratory personnel and is not a drug, food or cosmetic.\u003c\/p\u003e\n\u003cp\u003eBPC-157 is supplied exclusively for laboratory research use and is not intended for human or veterinary application.\u003c\/p\u003e\n\n\u003ch2\u003eResearch Applications (Observations from Studies)\u003c\/h2\u003e\n\u003cp\u003eBPC-157 has been examined across a range of preclinical research settings. The following describes areas of published investigation and does not constitute any claim regarding outcomes outside those experimental contexts.\u003c\/p\u003e\n\n\u003ch3\u003eTissue Organization and Structural Response Models\u003c\/h3\u003e\n\u003cp\u003eA substantial portion of the literature involves experimental models evaluating tissue organization and structural response following induced stress. Investigators in this area typically assess markers of cellular migration and matrix organization within defined animal model systems.\u003c\/p\u003e\n\n\u003ch3\u003eVascular and Microcirculatory Research\u003c\/h3\u003e\n\u003cp\u003eGiven the recurring nitric oxide and angiogenic findings, the peptide has been studied in connection with vascular signaling and microcirculatory behaviour in non clinical models, including examination of endothelial response and vessel formation dynamics.\u003c\/p\u003e\n\n\u003ch3\u003eGastrointestinal and Mucosal Research Models\u003c\/h3\u003e\n\u003cp\u003eReflecting its origin as a gastric protein fragment, BPC-157 has been examined extensively in gastrointestinal and mucosal research models. This remains among the most established areas of published investigation for the compound.\u003c\/p\u003e\n\n\u003ch3\u003eInflammatory Signaling and Cellular Stress Research\u003c\/h3\u003e\n\u003cp\u003eStudies have also investigated the peptide in relation to inflammatory signaling pathways and cellular stress response, examining how experimental systems behave under induced stress conditions in the presence of the compound.\u003c\/p\u003e\n\n\u003cp\u003eBPC-157 is supplied exclusively for laboratory research use and is not intended for human or veterinary application.\u003c\/p\u003e\n\u003ch2\u003eBPC-157 Compared With Related Research Compounds\u003c\/h2\u003e\n\u003cp\u003eThe table below places BPC-157 alongside two related compounds in the Peptsche range. It is offered to clarify differences in classification, molecular target and research context. It should not be read as a comparison of clinical performance, safety, or suitability for any application.\u003c\/p\u003e\n\u003ctable\u003e\u003ctbody\u003e\n\u003ctr\u003e\n\u003ctd\u003e\u003cstrong\u003eCharacteristic\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd\u003e\u003cstrong\u003eBPC-157\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd\u003e\u003cstrong\u003e\u003ca href=\"\/products\/tb-500\"\u003eTB-500\u003c\/a\u003e\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd\u003e\u003cstrong\u003e\u003ca href=\"\/products\/wolverine-blend\"\u003eWolverine Blend\u003c\/a\u003e\u003c\/strong\u003e\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003e\u003cstrong\u003eResearch Classification\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd\u003eSynthetic pentadecapeptide\u003c\/td\u003e\n\u003ctd\u003eSynthetic acetylated seven residue peptide\u003c\/td\u003e\n\u003ctd\u003eTwo component co lyophilized research blend\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003e\u003cstrong\u003ePrimary Molecular Target\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd\u003eNitric oxide and angiogenic signaling pathways\u003c\/td\u003e\n\u003ctd\u003eMonomeric G actin within the cytoskeleton\u003c\/td\u003e\n\u003ctd\u003eNitric oxide signaling and monomeric G actin, addressed by separate components\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003e\u003cstrong\u003eMechanistic Profile\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd\u003ePleiotropic activity across several signaling systems\u003c\/td\u003e\n\u003ctd\u003eActin sequestration and cytoskeletal reorganisation\u003c\/td\u003e\n\u003ctd\u003eTwo unrelated pathways, combination not studied in published work\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003e\u003cstrong\u003ePrimary Research Focus\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd\u003eTissue integrity, vascular and mucosal models\u003c\/td\u003e\n\u003ctd\u003eCell migration and endothelial models\u003c\/td\u003e\n\u003ctd\u003eVascular and cytoskeletal research in one preparation\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003e\u003cstrong\u003eStructural Design\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd\u003eFifteen residues, no unnatural residues or modification\u003c\/td\u003e\n\u003ctd\u003eSeven residues, N terminal acetyl group, free acid C terminus\u003c\/td\u003e\n\u003ctd\u003eMixture of two peptides, no single formula or CAS number\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003e\u003cstrong\u003eRegulatory Status\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd\u003eResearch use compound, not approved for human or veterinary use\u003c\/td\u003e\n\u003ctd\u003eResearch use compound, not approved for human or veterinary use, and listed by the United States Food and Drug Administration among bulk drug substances withdrawn from consideration for compounding\u003c\/td\u003e\n\u003ctd\u003eResearch use blend, neither component approved for human or veterinary use, and the TB-500 component appears on the United States Food and Drug Administration list of bulk drug substances withdrawn from consideration for compounding\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003c\/tbody\u003e\u003c\/table\u003e\n\u003cp\u003eBPC-157 is supplied exclusively for laboratory research use and is not intended for human or veterinary application.\u003c\/p\u003e\n\u003ch2\u003eLaboratory Handling and Storage Considerations\u003c\/h2\u003e\n\u003cp\u003eBPC-157 should be handled in accordance with institutional laboratory procedures and established practice for research peptides. Maintain storage conditions consistent with product documentation, keeping vials sealed and protected from heat, light and moisture. Record lot numbers, storage conditions and preparation methods in laboratory documentation, and retain certificates of analysis alongside study records to support reproducibility.\u003c\/p\u003e\n\n\u003ch3\u003eLaboratory Safety Considerations\u003c\/h3\u003e\n\u003cp\u003eBPC-157 should be handled in the same manner as other research compounds without a fully characterised toxicological profile.\u003c\/p\u003e\n\u003cul\u003e\n\u003cli\u003e\n\u003cstrong\u003ePersonal protective equipment:\u003c\/strong\u003e Use appropriate PPE including laboratory coat, nitrile gloves and eye protection.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eEngineering controls:\u003c\/strong\u003e Minimise generation of aerosols or dust. Conduct weighing and transfer procedures using suitable containment.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eExposure prevention:\u003c\/strong\u003e Avoid inhalation, ingestion and contact with skin or eyes. Do not taste or smell the material. Wash hands thoroughly after handling.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eStorage:\u003c\/strong\u003e Keep containers tightly sealed and protected from light and moisture under the conditions specified.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eSpill response:\u003c\/strong\u003e Address spills using appropriate PPE and institutional spill response procedures. Avoid dry sweeping.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eDisposal:\u003c\/strong\u003e Dispose of unused material, consumables and waste in accordance with local regulations and institutional programmes.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eDocumentation:\u003c\/strong\u003e Maintain all lot and handling records. Additional handling guidance is available on request.\u003c\/li\u003e\n\u003c\/ul\u003e\n\n\u003ch2\u003eCertificate of Analysis and Quality Assurance\u003c\/h2\u003e\n\u003cp\u003eEvery production lot of BPC-157 supplied by Peptsche undergoes analytical evaluation, and a batch specific Certificate of Analysis accompanies each order to support research documentation, quality control and experimental consistency.\u003c\/p\u003e\n\u003cp\u003eEach Certificate of Analysis typically includes:\u003c\/p\u003e\n\u003cul\u003e\n\u003cli\u003e\n\u003cstrong\u003eIdentity verification\u003c\/strong\u003e using analytical techniques such as mass spectrometry to confirm the molecular characteristics of the material supplied.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003ePurity analysis\u003c\/strong\u003e performed by high performance liquid chromatography to quantify purity and identify potential impurities.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eBatch documentation\u003c\/strong\u003e recording lot number, testing date, analytical methods applied and quality assessment results.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eTraceability information\u003c\/strong\u003e to support laboratory recordkeeping and reproducibility across research workflows.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp\u003ePeptsche works with Janoshik Analytical, an independent testing laboratory, for third party verification of research material quality. Independent testing provides transparency and confidence in product identity, consistency and sourcing, and batch specific documentation can be retained as part of laboratory records and internal quality procedures.\u003c\/p\u003e\n\u003cp\u003eBPC-157 is supplied exclusively for laboratory research use and is not intended for human or veterinary application.\u003c\/p\u003e\n\u003ch2\u003eFrequently Asked Questions\u003c\/h2\u003e\n\u003ch3\u003eWhat is BPC-157?\u003c\/h3\u003e\n\u003cp\u003eBPC-157 is a synthetic pentadecapeptide whose sequence corresponds to a partial sequence of Body Protection Compound, a protein fragment originally isolated from gastric juice. Peptsche supplies it as a lyophilized powder of high analytical purity, sealed in glass vials for controlled laboratory investigation.\u003c\/p\u003e\n\u003ch3\u003eWhat is BPC-157 studied for in research?\u003c\/h3\u003e\n\u003cp\u003ePublished investigation is preclinical and spans tissue organization and structural response models, vascular and microcirculatory research, gastrointestinal and mucosal research models, and inflammatory signaling and cellular stress research. These describe areas of laboratory study rather than established outcomes outside those experimental contexts.\u003c\/p\u003e\n\u003ch3\u003eHow does BPC-157 work in laboratory research?\u003c\/h3\u003e\n\u003cp\u003eIn experimental models BPC-157 demonstrates pleiotropic activity, interacting with several signaling systems rather than a single well defined receptor target. Recurring themes across published work include modulation of nitric oxide and vascular signaling, influence on angiogenic and endothelial responses, and regulation of cellular stress and inflammatory balance.\u003c\/p\u003e\n\u003ch3\u003eHow is the quality of Peptsche BPC-157 verified?\u003c\/h3\u003e\n\u003cp\u003eEvery production lot of Peptsche BPC-157 is evaluated analytically, with identity confirmed using techniques such as mass spectrometry and purity quantified by high performance liquid chromatography. Peptsche works with Janoshik Analytical, an independent testing laboratory, for third party verification, and a batch specific Certificate of Analysis accompanies each order.\u003c\/p\u003e\n\u003ch3\u003eHow should unopened BPC-157 be stored?\u003c\/h3\u003e\n\u003cp\u003eUnopened vials should be stored sealed at 2 to 8 °C, protected from heat, light and moisture. Vials should reach ambient temperature before opening, and lot number, storage conditions and preparation date should be recorded in laboratory documentation so results stay traceable to a batch.\u003c\/p\u003e\n\u003ch3\u003eIs BPC-157 intended for human use?\u003c\/h3\u003e\n\u003cp\u003eNo. BPC-157 is supplied strictly for laboratory research use only. It is not approved for human consumption, veterinary use, diagnosis, treatment or any medical application.\u003c\/p\u003e\n\u003ch3\u003eWhy do researchers choose Peptsche for BPC-157?\u003c\/h3\u003e\n\u003cp\u003ePeptsche supplies BPC-157 at 99% or greater purity by HPLC, verified per batch, sealed under inert conditions with batch specific analytical documentation. Independent third party verification and full lot traceability support reproducibility across research workflows.\u003c\/p\u003e\n\u003ch2\u003eScientific References\u003c\/h2\u003e\n\u003col\u003e\n\u003cli\u003eSeiwerth S, Brcic L, Vuletic LB, Kolenc D, Aralica G, Misic M, Zenko A, Drmic D, Rucman R, Sikiric P. BPC 157 and blood vessels. \u003cem\u003eCurrent Pharmaceutical Design\u003c\/em\u003e. 2014;20(7):1121 to 1125. \u003ca href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/23782145\/\" target=\"_blank\" rel=\"noopener\"\u003ehttps:\/\/pubmed.ncbi.nlm.nih.gov\/23782145\/\u003c\/a\u003e\n\u003c\/li\u003e\n\u003cli\u003eHsieh MJ et al. Modulatory effects of BPC 157 on vasomotor tone and the activation of Src Caveolin 1 endothelial nitric oxide synthase pathway. \u003cem\u003eScientific Reports\u003c\/em\u003e. 2020. \u003ca href=\"https:\/\/www.nature.com\/articles\/s41598-020-74022-y\" target=\"_blank\" rel=\"noopener\"\u003ehttps:\/\/www.nature.com\/articles\/s41598-020-74022-y\u003c\/a\u003e\n\u003c\/li\u003e\n\u003cli\u003eJózwiak M et al. Multifunctionality and Possible Medical Application of the BPC 157 Peptide. Literature and Patent Review. \u003cem\u003ePharmaceuticals\u003c\/em\u003e. 2025;18:185. \u003ca href=\"https:\/\/www.mdpi.com\/1424-8247\/18\/2\/185\" target=\"_blank\" rel=\"noopener\"\u003ehttps:\/\/www.mdpi.com\/1424-8247\/18\/2\/185\u003c\/a\u003e\n\u003c\/li\u003e\n\u003c\/ol\u003e\n\n\u003ch2\u003eRESEARCH USE ONLY\u003c\/h2\u003e\n\u003cp\u003eThese compounds are NOT intended for human consumption, clinical use, or veterinary applications. We are not affiliated with any pharmaceutical companies or their commercial medications. By placing an order, you certify these materials will be used exclusively for in vitro testing and laboratory experimentation only. Bodily introduction of any kind into humans or animals is strictly forbidden by law. This product should only be handled by licensed, qualified professionals. This product is not a drug, food, or cosmetic and may not be misbranded, misused or mislabeled as a drug, food or cosmetic.\u003c\/p\u003e","brand":"Peptsche","offers":[{"title":"10mg","offer_id":43752703295551,"sku":"PEP-BPC157-10MG","price":60.0,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0675\/7394\/0287\/files\/peptsche_BPC157_5mg.png?v=1786899685","url":"https:\/\/peptsche.com\/products\/bpc-157","provider":"Peptsche","version":"1.0","type":"link"}